UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000048167
Receipt No. R000054864
Scientific Title A Prospective Observational Study Evaluating the Efficacy of an Induction Protocol of Ventricular Premature Complexes Originated from Outflow Tract in Catheter Ablation
Date of disclosure of the study information 2022/06/25
Last modified on 2022/06/25 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A Prospective Observational Study Evaluating the Efficacy of an Induction Protocol of Ventricular Premature Complexes Originated from Outflow Tract in Catheter Ablation
Acronym A Prospective Observational Study Evaluating the Efficacy of an Induction Protocol of Ventricular Premature Complexes Originated from Outflow Tract in Catheter Ablation
Scientific Title A Prospective Observational Study Evaluating the Efficacy of an Induction Protocol of Ventricular Premature Complexes Originated from Outflow Tract in Catheter Ablation
Scientific Title:Acronym A Prospective Observational Study Evaluating the Efficacy of an Induction Protocol of Ventricular Premature Complexes Originated from Outflow Tract in Catheter Ablation
Region
Japan

Condition
Condition Ventricular arrhythmia
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the predictor of a procedural success in cahter ablation therapy for ventricular premature complexes originated from outflow tract
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes A predictor of a procedural success in cahter ablation therapy for ventricular premature complexes originated from outflow tract
Key secondary outcomes 1. A burden of premature ventricular complexes by each indcution protocol
2. A burden of premature ventricular complexes accoring to the origin of premature ventricular complexes
3. A predictor of the recurrence of premature ventricular complexes during follow up period
4. Relationship between the induction protocol and the burden or time with ventricular complexes
5. Adverse event by the induction protocols

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1.Age older than 20 years
2.The patient is willing and able to comply with the protocol and has provided written informed consent
Key exclusion criteria The patient who the investigators admit is not not appropriate to include in the study
Target sample size 100

Research contact person
Name of lead principal investigator
1st name Masaya
Middle name
Last name Watanabe
Organization Hokkaido University Hospital
Division name Department of cardiovascular medicine
Zip code 060-8638
Address North 15, West 7, Kita-ku, Sapporo city
TEL 0117066973
Email m.watanabe@huhp.hokudai.ac.jp

Public contact
Name of contact person
1st name Masaya
Middle name
Last name Watanabe
Organization Hokkaido University
Division name Department of cardiovascular medicine
Zip code 060-8638
Address North 15, West 7, Kita-ku, Sapporo city
TEL 0117066973
Homepage URL
Email m.watanabe@huhp.hokudai.ac.jp

Sponsor
Institute Department of Cardiovascular Medicine
Hokkaido University Graduate School of Medicine
Institute
Department

Funding Source
Organization Department of Cardiovascular Medicine
Hokkaido University Graduate School of Medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Hokkaido University Hospital
Address North 15, West 7, Kita-ku, Sapporo city
Tel 0117066973
Email m.watanabe@huhp.hokudai.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 06 Month 25 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2021 Year 11 Month 02 Day
Date of IRB
2021 Year 11 Month 02 Day
Anticipated trial start date
2021 Year 11 Month 26 Day
Last follow-up date
2033 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information none

Management information
Registered date
2022 Year 06 Month 25 Day
Last modified on
2022 Year 06 Month 25 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054864